OA
ENTA icon

OFI Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

OFI Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$106K Buy
+2,941
New +$126K 0.01% 1461

Other funds holding ENTA

ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

OFI Advisors's ENTA Position: Q3 2015 in Review

OFI Advisors opened a new position in Enanta Pharmaceuticals (ENTA) in Q3 2015: 2,941 shares worth $106K. The stake represents 0.01% of the portfolio and ranks #1461 among its holdings.

144 funds tracked by Wall St. Rank hold ENTA as of Q3 2015.

  • OFI Advisors held 2,941 shares of Enanta Pharmaceuticals worth $106K as of Q3 2015.
  • Enanta Pharmaceuticals was a new OFI Advisors position in Q3 2015.
  • Enanta Pharmaceuticals made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1461 holding.
  • 144 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.